EULAR and ACR responses in RF-positive and RF-negative patients at week 24
| Efficacy measure | RF-positive (n=184) | RF-negative (n=81) |
|---|---|---|
| Mean±SD DAS28 at baseline | 6.1±1.0 | 5.7±1.1 |
| Remission (DAS28 <2.6) | 46.2% (85) | 50.6% (41) |
| LDAS (DAS28 ≤3.2) | 57.1% (105) | 59.3% (48) |
| Clinically significant DAS28 reduction ≥1.2 | 79.3% (146) | 70.4% (57) |
| EULAR good response | 56.0% (103) | 58.0% (47) |
| ACR50 | 50.5% (93) | 50.6% (41) |
| ACR70 | 33.7% (62) | 34.6% (28) |
Data shown as percentage (n) unless otherwise stated.
ACR, American College of Rheumatology; DAS, Disease Activity Score; EULAR, European League Against Rheumatism; LDAS, Low Disease Activity Score; RF, rheumatoid factor.